NO902548D0 - Fremgangsmaate for fremstilling av fenamat-1,3,4-tiadiazoler og 1,3,4 oksadiazoler. - Google Patents

Fremgangsmaate for fremstilling av fenamat-1,3,4-tiadiazoler og 1,3,4 oksadiazoler.

Info

Publication number
NO902548D0
NO902548D0 NO902548A NO902548A NO902548D0 NO 902548 D0 NO902548 D0 NO 902548D0 NO 902548 A NO902548 A NO 902548A NO 902548 A NO902548 A NO 902548A NO 902548 D0 NO902548 D0 NO 902548D0
Authority
NO
Norway
Prior art keywords
phenamate
oxadiazoles
thiadiazoles
procedure
preparation
Prior art date
Application number
NO902548A
Other languages
English (en)
Other versions
NO902548L (no
Inventor
Diane Harris Boschelli
David Thomas Connor
Milton Louis Hoefle
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO902548D0 publication Critical patent/NO902548D0/no
Publication of NO902548L publication Critical patent/NO902548L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
NO90902548A 1989-06-09 1990-06-08 Fremgangsmaate for fremstilling av fenamat-1,3,4-tiadiazoler og 1,3,4 oksadiazoler. NO902548L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36440789A 1989-06-09 1989-06-09
US50676890A 1990-04-12 1990-04-12

Publications (2)

Publication Number Publication Date
NO902548D0 true NO902548D0 (no) 1990-06-08
NO902548L NO902548L (no) 1990-12-10

Family

ID=27002463

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90902548A NO902548L (no) 1989-06-09 1990-06-08 Fremgangsmaate for fremstilling av fenamat-1,3,4-tiadiazoler og 1,3,4 oksadiazoler.

Country Status (11)

Country Link
US (1) US5462952A (no)
EP (1) EP0401857A3 (no)
JP (1) JP3086692B2 (no)
KR (1) KR910000684A (no)
AU (1) AU627034B2 (no)
CA (1) CA2018517A1 (no)
FI (1) FI902771A0 (no)
NO (1) NO902548L (no)
NZ (1) NZ233981A (no)
PH (1) PH26910A (no)
PT (1) PT94328A (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212189A (en) * 1991-12-17 1993-05-18 Warner-Lambert Company Thiadiazole or oxadiazole analogs of fenamic acids containing substituted hydroxamate side chains as antiinflammatory agents
US5578639A (en) * 1994-07-01 1996-11-26 Warner-Lambert Company PLA2 inhibitors and their use for inhibition of intestinal cholesterol absorption
US6310060B1 (en) 1998-06-24 2001-10-30 Warner-Lambert Company 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as MEK inhibitors
ATE445838T1 (de) 2001-07-25 2009-10-15 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
ES2728225T3 (es) 2009-02-20 2019-10-23 2 Bbb Medicines B V Sistema de administración de fármacos a base de glutatión
US8445002B2 (en) 2009-05-06 2013-05-21 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
JP2020518669A (ja) 2017-05-03 2020-06-25 ビバーチェ セラピューティクス，インク． 非縮合三環式化合物
US11192865B2 (en) 2017-08-21 2021-12-07 Vivace Therapeutics, Inc. Benzosulfonyl compounds
WO2019113236A1 (en) 2017-12-06 2019-06-13 Vivace Therapeutics, Inc. Benzocarbonyl compounds
US11661403B2 (en) 2018-05-16 2023-05-30 Vivace Therapeutics, Inc. Oxadiazole compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH479599A (de) * 1965-04-12 1969-10-15 Bristol Myers Co Verfahren zur Herstellung von Verbindungen von Nitrilen mit Stickstoffwasserstoffsäure oder Aziden
GB1166861A (en) * 1966-01-15 1969-10-15 Aspro Nicholas Ltd New Diphenylamine Derivatives and Compositions containing them
DE1930263B2 (de) * 1969-06-13 1976-11-11 Agfa-Gevaert Ag, 5090 Leverkusen Verfahren zur herstellung photographischer silberbilder
DE3270324D1 (en) * 1982-01-22 1986-05-07 Basf Ag Aminothiadiazoles, process for their preparation and their use in combating unwanted plant growth
IL90192A0 (en) * 1988-05-13 1989-12-15 Schering Ag Azole ether derivatives and pesticidal compositions containing the same

Also Published As

Publication number Publication date
AU5690490A (en) 1990-12-13
PT94328A (pt) 1991-02-08
EP0401857A2 (en) 1990-12-12
KR910000684A (ko) 1991-01-30
NZ233981A (en) 1992-10-28
US5462952A (en) 1995-10-31
PH26910A (en) 1992-12-03
JPH0374375A (ja) 1991-03-28
NO902548L (no) 1990-12-10
FI902771A0 (fi) 1990-06-04
AU627034B2 (en) 1992-08-13
EP0401857A3 (en) 1991-07-31
JP3086692B2 (ja) 2000-09-11
CA2018517A1 (en) 1990-12-09

Similar Documents

Publication Publication Date Title
NO892083D0 (no) Fremgangsmaate for fremstilling av arylmetylenyl-derivaterav tiazolidinoner, imidazolidinoner og oksazolidinoner.
NO911432L (no) Fremgangsmaate for fremstilling av 3,5-disubstituerte 2-isoksazoliner og isoksazoler.
NO894539L (no) Fremgangsmaate for fremstilling av nye 2'-halomethyliden-,2'-ethenyliden- og 2'-ethynylcytidin-, uriden og guanosinderivater.
NO885454D0 (no) Fremgangsmaate for fremstilling av triklormonosilan.
NO902548L (no) Fremgangsmaate for fremstilling av fenamat-1,3,4-tiadiazoler og 1,3,4 oksadiazoler.
NO894210L (no) Fremgangsmaate for fremstilling av kinolyloxazol-2-oner.
NO895176L (no) Fremgangsmaate ved fremstilling av mono-n-alkylerte polyazamakrocykler.
NO894649D0 (no) Fremgangsmaate for fremstilling av (s)-alfa-ethyl-2-oxo-1-pyrrolidinacetamid.
NO893826D0 (no) Fremgangsmaate for fremstilling av 2'-halomethyliden, 2'-ethenyliden og 2'-ethenyladenosinderivater.
NO895032D0 (no) Fremgangsmaate for fremstilling av 2-benzotiazoliner.
NO900643L (no) Fremgangsmaate for fremstilling og anvendelse av 2,3,23-trihydroksi-urs-12-ener og deres derivater.
NO890159D0 (no) Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler.
NO903347D0 (no) Fremgangsmaate for fremstilling av 14,17alfa-ethano- og ethanooestratriener.
NO882335L (no) Fremgangsmaate for fremstilling av 5-(omega-ammonio-acyloksy-metylen)-tetrahydrofuraner og -tetrahydrotiofener.
NO881713D0 (no) Fremgangsmaate for fremstilling av di-t-butylfenyl-alkyl og benzylethere.
NO891985L (no) Fremgangsmaate for fremstilling av dibenzotiofen- og tioxanten-derivater.
NO883986L (no) Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter.
NO921086D0 (no) Fremgangsmaate for fremstilling og anvendelse av substituerte 2',3'-didesoksy-5-trifluormetyluridiner
NO905543L (no) Fremgangsmaate for fremstilling og anvendelse av aminopyridinylmetanoler og aminometylpyridinaminer.
NO895040D0 (no) Fremgangsmaate for fremstilling av polyhydroxybenzyloxypropanolaminer.
NO900219D0 (no) Dihydroksybenzofenon-oksim, samt fremgangsmaate for fremstilling av slike oksimer.
NO904108L (no) Fremstilling av 2,6-dioksypiperidinderivater.
NO891987D0 (no) Fremgangsmaate for fremstilling av n-substituerte fenyltioaniliner, fenylsulfinylaniliner og fenylsulfonylaniliner.
NO912279L (no) Fremgangsmaate for fremstilling og anvendelse av eksplosjonssikre 1-dimetylamino-3-dimetylimino-2-arylprop-1-en-salter.
NO890539D0 (no) Fremgangsmaate for fremstilling av lipofile oxadiazoler.